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Fig. 1-5 Uptake of ceftibuten (A) and cephradine (B) by oocytes injected with water or
rat PEPTI cRNA. Uptake by oocytes was assayed for 1 hr at 25eC in the presence of either cefubuten (1
mM) or cephradine (3 mM). Each column represents the mean ± S.E. of three experiments. Four oocytes
were used fbr each uptake experiment.
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Fig. 1-6 Effects of various compounds on the uptake of ceftibuten (A) and cephradine
(B) into oocytes. Uptake of ceftibuten (1 mM) or cephradine (3 mM) by oocytes was assayed for 1 hr at
25eC in the uptake medium (pH 6,O) containmg each inhibitor (10 mM). Each column represents the mean
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Fig. 1-8 Comparison of deduced amino
(bottom) of the rat PEPTI and PEPT2.
membrane-spanning a-helices are underlined.
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Fig. 1-11 ['"C]Gly-Sar uptake by oocytes injected with water, rat PEPTI or rat PEPT2
cRNA. Uptake by oocytes was assayed for 2 hr at 250C in the presence of 20 pM [i`C]Gly-Sar Each


















Fig. 1-12 Effect of medium pH on [3H]Bestatin uptake by oocytes
injected with water, rat PEPTI or rat PEPT2 cRNA. Uptake by oocytes was
assayed fbr 2 hr at 250C in the presence of 30 pM [3H]Bestatin Each column represents
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Fig. 2-2 Uptake of B-lactam antibiotics and [3H]Bestatin by LLC-pBK (A) and
LLC-rPEPTI cells (B). The cell monolayers were incubated for 1 hr at 370C in the incubation medium
at pH 6.0 (shaded columns) or pH 7.4 (open columns) containing each dmg (1 mM). Each column
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Fig. 2-3 The pH dependence of ceftibuten (A) and cephradine (B) uptake by
LLC-rPEPTI and LLC-pBK cells. LLC-rPEPTI (e) or LLC-pBK cells (O) were incubated for 1 hr
at 370C with l mM ceftibuten or cephradine at various pH values. Each point represents the mean ± S.E.
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Fig. 2-4 Effects of various compounds on ceftibuten (A) and cephradine (B) uptake by
LLC-rPEPTI cells. LLC-rPEPTI cells were mcubated for 15 min at 37eC with 1 mM ceftibuten (pH
6 O) or cephradme (pH 6.0) in the absence or presence of each mhibitor (1O mM), except for cimetidme and
cefubuten (5 mM) Each column represents the mean ± S.E of three monolayers GLY, glycine;
GLY-LEU, glycylleucine; GLY-SAR, glycylsarcosine, GLY-GLY-PHE, glycylglycylphenylalanme; TEA,
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             ' Fig. 2-6 The pH dependence of ['`C]Gly-Sar uptake by LLC-rPEPTI (A) and
 LLC-rPEPT2 cells (B). Each cell was incubated for 15 min at 370C with incubation medium of
 various pHs containing 20 pM [i4C]Gly-Sar. Each point represents the mean ± S.E. of three monolayers.
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Fig. 2-7 Concentration dependence of ['4C]Gly-Sar uptake by LLC-rPEPTI (A) and
LLC-rPEPT2 cells (B). [i`C]Gly-Sar uptake by LLC-rPEPTI andLLC-rPEPT2 cellswas measuredat
various concentrations (20-5,Ooo ptM for LLC-rPEPTI and 5-1,OOO pM for LLC-rPEPT2 cells) for 15 min
at 370C in the absence (e) or presence (O) of 10 mM unlabeled Gly-Sar. Each point represents the mean ±
S.E. of three monolayers. When the error bar is not shown, it is smaller than the symbol. Inset:
Eadie-Hofstee plots of the uptake after correction for the nonsaturable component; V, uptake rate (nmollmg


















































Table 2-1.Inhibition constants (Ki) of various dipeptides fbr Gly-Sar uptake

















































  Each value is mean of two monolayers. LLC-rPEPTI and LLC-rPEPT2 cells were incubated for 15 min at
37eC with incubation medium containing [i4C]Gly-Sar (20 pM) in the presence of each dipeptide. The
apparent inhibition constant (Ki) values were caluculated from the inhibition plots based on the transformed
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Fig. 2-9 Inhibition of ['`C]GIy-Sar uptake by P-lactam antibiotics in LLC-rPEPTI (A)
and LLC-rPEPT2 cells (B). Each transfectant was incubated fbr 15 min at 37"C with incubation medium
containing [i4C]Gly-Sar (20 pM) in the absence (O) or presence of increasing concentration of cyclacillin (-),
cefadroxi1 (e) and ceftibuten (A). Each point represents the mean of two monolayers.
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Table 2-2. Inhibition constants (Ki) of P-lactam antibiotics and Bestatin
         for Gly-Sar uptake by LLC-rPEPTI and LLC-rPEPT2 ceHs
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 Each value is mean of two monolayers. LLC-rPEPTI and LLC-rPEPT2 cells were incubated for l5 min at
370C with incubation medium containing [i"C]Gly-Sar (20 pM) in the presence of each competitor. The
apparent inhibition constant (Ki) values were caluculated from the inhibition plots based on the transformed


















































































































































































O 10 100 1000 104







o O  10 100 1000 104
 CONCENTRATION (pM)
Fig. 3-3 Effect of cephradine and ceftibuten concentration on the DEPC-induced inhibition
of ['`C]Gly-Sar uptake by LLC-rPEPTI (A) and LLC-rPEPT2 cells (B). The cells were
preincubated at 25eC for 10 min with 1 mM DEPC (pH 6.0) in the absence (O) or the presence of an increasing
concentration of cephradine (A) and ceftibuten (e). After preincubation, the cells were rinced once with
incubation medium and then incubated with [i4C]Gly-Sar (20 pM, pH 6.0) for 15 min at 37eC. Each point
represents the mean of two monolayers except for the control.
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Fig. 3-4 Effect of various dipeptides with different charge, cephradine, and ceftibuten on
the DEPC-induced inhibitien of ['`C]Gly-Sar uptake (A) and on [i`C]Gly-Sar uptake (B) by
LLC-rPEPTI cells. A, LLC-rPEPTI cells were preincubated at 25"C for 10 min with 1 mM DEPC (pH
6.0) in the absence or the presence of various substrates. After preincubation, the cells were rinced once with
incubation medium and then incubated with [i`C]Gly-Sar (20 pM, pH 6.0) fbr 15 min at 370C. B,
LLC-rPEPTI cells were incubated with [i`C]Gly-Sar (20 yM, pH 6.0) for 15 min at 370C in the absence or the







































































































































Fig. 3-9 Schematic representation of PEPTI (black), PEPT2 (gray), and construeted
chimeras. All the proteins are represented as possesing twelve putative membrane-spanning domains with
their COOH and NH2 termini within the cytoplasm. The chimera with transmembrane domains 1-6 of PEPTI
arxl 7-12 of PEPT2 vvas designated as PEPT-NIC2, arxi the reciprocal chimera was named as PEPT-N2C1.
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Fig. 3-10 Expression of PEPT-NIC2 and PEPT-N2Cl mRNA in transfectants. Total RNA
isolated from LLC-NIC2 and LLC-N2Cl cells was reverse transcribed. The synthesized PEPT-NIC2 cDNA
(lanes 1 and2) and PEPT-N2Cl cDNA (lanes 3cvid4) were amplified with sets ofprimers as fo11ows: lane I
and3, sence and antisence primers were used for PEPrl- and PEPI'2-specific sequences, respectively; lane 2
and4, sence and antisence primers wene used forPEPT2- and PEPTI-specific sequences, respectively. The
junction sites of chimeric cDNAs were included between the sence and antisence primers. PCR products were
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Fig. 3-12 Concentration dependence of [i`C]Gly-Sar uptake by LLC-NIC2 (A) and LLC-N2Cl
cells (B). ['`C]Gly-Sar uptake by LLC-NIC2 and LLC-N2Cl cells was measured at various concentrations for l5
and60 min, respectively, at 370C in the absence (e) or presence(O) of 10 mM unlabeled Gly-Sar. Each point
represents the mean ± S.E. of three monolayers. Inset: Eadie-Hofstee plots of the uptake after correction fbr the
nonsaturable component; V, uptake rate (nmollmg proteinl15 min or hr); S, Gly-Sar concentration (mM).
             Table 3-1. Inhibition constants (Ki) of P-lactam antibiotics for







































  Ki values for PEPT1 and PEPT2 were taken from Table 2-1. Each value for PEPT-NIC2 and PEPT-N2C1
is mean of two monolayers. LLC-NIC2 and LLC-N2Cl cells were incubated for 15 and 60 min, respectively,
at 37eC with incubation medium containing [i4C]Gly-Sar (20 pM) in the presence of each competitor. The
apparent inhibition constant (Ki) values were caluculated from the inhibition plots based on the transforrned
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